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Abstract
Background: DHCR24, involved in the de novo synthesis of cholesterol and protection of neuronal cells against
different stress conditions, has been shown to be selectively downregulated in neurons of the affected brain areas in
Alzheimer’s disease.
Methods: Here, we investigated whether the overexpression of DHCR24 protects neurons against inflammation-induced
neuronal death using co-cultures of mouse embryonic primary cortical neurons and BV2 microglial cells upon acute
neuroinflammation. Moreover, the effects of DHCR24 overexpression on dendritic spine density and morphology in
cultured mature mouse hippocampal neurons and on the outcome measures of ischemia-induced brain damage in vivo
in mice were assessed.
Results: Overexpression of DHCR24 reduced the loss of neurons under inflammation elicited by LPS and IFN-γ treatment
in co-cultures of mouse neurons and BV2 microglial cells but did not affect the production of neuroinflammatory
mediators, total cellular cholesterol levels, or the activity of proteins linked with neuroprotective signaling. Conversely, the
levels of post-synaptic cell adhesion protein neuroligin-1 were significantly increased upon the overexpression of DHCR24
in basal growth conditions. Augmentation of DHCR24 also increased the total number of dendritic spines and the
proportion of mushroom spines in mature mouse hippocampal neurons. In vivo, overexpression of DHCR24 in striatum
reduced the lesion size measured by MRI in a mouse model of transient focal ischemia.
Conclusions: These results suggest that the augmentation of DHCR24 levels provides neuroprotection in acute stress
conditions, which lead to neuronal loss in vitro and in vivo.
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Background
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder and the most common form of dementia world-
wide. AD is neuropathologically characterized by the de-
position of β-amyloid plaques and neurofibrillary tangles in
the neocortex of the brain. β-Amyloid plaques are com-
posed of β-amyloid (Aβ) peptides, released from amyloid
precursor protein (APP) as a result of sequential proteolytic
cleavage by β- (BACE1) and γ-secretases [1]. According to
the amyloid cascade hypothesis, impaired balance between
the production and clearance leads to accumulation of Aβ,
which triggers downstream events in AD pathology, such
as formation of neurofibrillary tangles and induction of
neuroinflammation and oxidative stress [2].
DHCR24 (3-β-hydroxysteroid-Δ-24-reductase), also
known as seladin-1 (selective Alzheimer’s disease
indicator-1), was initially identified as being expressed at
lower levels in the affected as compared to unaffected
brain regions in AD patients [3, 4]. Thus, it was suggested
to represent a selective indicator of AD pathogenesis.
More recently, the idea that DHCR24 downregulation
would selectively indicate AD pathogenesis [3] has been
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questioned [5]. On the other hand, genetic polymorphisms
in DHCR24 may modulate the risk of developing AD in
humans [6], suggesting that DHCR24 could be genetically
associated with AD. Functionally, DHCR24 protein is
characterized as a multifunctional enzyme having two
distinctive activities: cholesterol-producing activity, i.e.,
reduction of desmosterol to cholesterol, mediated by the
C-terminal region, and H2O2-scavenging activity brought
about by the oxidoreductase domain near the N-terminus
[7, 8]. An accumulating body of evidence strongly suggests
that DHCR24 has neuroprotective properties, which
might be associated with these activities. DHCR24 has
proven protective in different AD-related stress condi-
tions, including Aβ-induced, oxidative, or endoplasmic
reticulum (ER) stress [3, 9–13]. Moreover, DHCR24 has a
pivotal role in the de novo synthesis of cholesterol. Brain
cholesterol, which is fundamental to the synaptic forma-
tion and normal functioning of the brain, is decreased
during both AD and normal aging [14]. In vitro studies
suggest that decreased cholesterol levels could contribute
to AD in various ways, including increased inflammatory
response and increased production or decreased clearance
of Aβ [15–17]. Furthermore, decreased levels of DHCR24
lead to the stabilization of BACE1 and consequently to
increased β-amyloidogenic processing of APP under
apoptotic conditions in vitro [18]. These findings suggest
that augmentation of DHCR24 levels in the affected brain
areas might provide a potential therapeutic approach to
intervene in AD pathogenesis.
To test if enhanced expression of DHCR24 leads to
neuroprotection, we have investigated the effects of
DHCR24 overexpression in in vitro and in vivo models
upon neuroinflammation. Here, we report for the first
time that DHCR24 protects neurons from death upon
neuroinflammation induced by lipopolysaccharide (LPS)
and interferon γ (IFN-γ) in a neuron-BV2 microglial cell
co-culture model. Furthemore, mechanistic elucidation
revealed that upon neuroinflammation, the overexpres-
sion of DHCR24 did not increase total cellular choles-
terol content or APP levels, nor did it affect Akt- or
ERK-related neuronal survival pathways or caspase-3 ac-
tivation in the co-cultures. Importantly, overexpression
of DHCR24 increased the total number of dendritic
spines and the relative proportion of mushroom spines
in mature mouse hippocampal neurons in vitro as well
as regionally reduced lesion size in vivo in a mouse
model of transient focal cerebral ischemia.
Methods
Lentiviral constructs
Human DHCR24 cDNA in pLenti-III-HA vector
(pLenti-CMV-h-DHCR24) and empty pLenti-III-HA
plasmid (both obtained from Applied Biological
Materials, Richmond, BC, Canada) as well as green
fluorescent protein (GFP) under the chicken beta actin
(CAG) promoter was cloned into lentivirus transfer (HIV)
plasmid and was packed into third-generation self-
inactivating lentiviral particles in the BioCenter Kuopio
National Virus Vector Laboratory in Kuopio, Finland.
Mouse primary cortical neuron and BV2 cell co-culture
and lentivirus-mediated gene transfer
Mouse primary cortical neurons were harvested from
18-embryonic-day-old JAXC57BL/6J mouse pups.
Single-cell suspension was prepared from the dissected
cortices by trypsin digestion and trituration, and the
cells were plated on poly-D-lysine-coated cell culture
plates in Neurobasal feeding medium containing 2%
B27, 2 mM L-glutamine, 100 U/ml penicillin, and
100 μg/ml streptomycin. Neurobasal feeding medium
and B27 are serum-free and thus do not contain choles-
terol. Cells were grown in a humidified incubator at 37 °
C in 5% CO2. After 4 days in vitro (DIV), half of the
medium was changed to feed the neurons. On DIV4,
DHCR24 and control lentiviral particles were used to in-
fect the cells at multiplicity of infection (MOI) 75. After
24 h of lentiviral infection (DIV5), the medium contain-
ing the lentiviral particles was removed. BV2 cells were
added to the cultures at 1:5 ratio on DIV5 and let to
attach for 2 h, after which the neuroinflammation was
induced with 200 ng/ml LPS and 20 ng/ml IFN-γ. The
anti-inflammatory cytokine interleukin 10 (IL-10, 50 ng/
ml, Peprotech) and the inducible nitric oxide synthase
(iNOS) inhibitor 1400 W (20 μM, Tocris) were used as
positive controls and were added 1 h after seeding of
BV2 cells to the co-cultures. Consequently, after the 1-h
pre-treatment with IL-10 and 1400 W, neuroinflamma-
tion was induced with 200 ng/ml LPS and 20 ng/ml
IFN-γ. Samples were collected on DIV7, 48 h after the
induction of neuroinflammation.
Immunofluorescence microscopy
The neurons and BV2 cells were plated on poly-D-lysine-
coated glass coverslips in 48-well cell culture plates. All the
following steps were performed at room temperature unless
otherwise noted. The cells were fixed in 4% paraformalde-
hyde for 20 min and permeabilized in ice-cold methanol for
8 min at − 20 °C. Unspecific antibody binding was blocked
by incubation in blocking solution (PBS containing 1%
bovine serum albumin and 10% normal goat serum) for
20 min. The cells were double-stained with mouse anti-
MAP2 (1:2000, Sigma, M9942; neuronal marker) and rat
anti-CD11b (1:300, Serotec, MCA74G; microglial cell
marker) or rabbit anti-GFAP (1:300, Dako, Z0334; astrocyte
marker) primary antibodies at + 4 °C overnight, followed by
staining with anti-mouse-Alexa488 (1:500, Invitrogen) and
anti-rabbit-Alexa594 (1:500, Invitrogen,) or anti-rat
Alexa594 (1:500, Abcam) secondary antibodies for 1 h.
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Cells without any of the primary antibodies were used as
negative controls for background staining. In between the
antibody incubations, the cells were washed three times in
PBS for 10 min. The nuclei were stained with 4′,6-diami-
dino-2-phenylindole (DAPI, 1:5000 in PBS, Sigma) for
5 min. The coverslips were mounted on objective slides
using GelMount mounting media (Sigma). Cells were
imaged using a Zeiss Axio Imager fluorescence microscope
at × 10 magnification, and images were prepared using the
Zeiss ZEN 2012 program. The number of different cell
types (neurons, astrocytes and BV2 cells) in the co-cultures
was quantified from five different images taken from three
individual wells each in every experiment. All in all, on
average 7000 cells were counted in each replicate. Addition
of BV2 cells onto the neuronal cultures was observed to
decrease the number of neurons by approximately 30% as
assessed by the MAP2 immunocytochemistry-based
neuronal viability assay (described below). Therefore, the
quantified values were normalized for the decrease in
neuronal number by dividing with the value of 1.3.
Protein extraction and western blot analysis
Total protein lysates for Western blot were prepared by
lysing the cells in T-PER tissue protein extraction
reagent (Thermo Scientific) supplemented with protease
and phosphatase inhibitor cocktails (× 100, Thermo
Scientific) and centrifuging at 10000×g for 10 min. BCA
protein assay kit (Thermo Scientific) was used to
determine protein concentrations, and 15–30-μg protein
samples were separated on NuPAGE 4–12% BisTris gel
(Life Technologies) and subsequently blotted onto a
PVDF membrane. Following antibodies were used to
probe the blots: Akt (1:1000, Cell Signaling Technology),
p-Akt recognizing Akt phosphorylated at Ser473
(1:1000, Cell Signaling Technology), APP C-terminus
(A8717, 1:2000, Sigma), BACE1 (D10E5, 1:1000, Cell
signaling technology), caspase-3 (1:1000, Cell Signaling
Technology), DHCR24 (C59D8, 1:800, Cell Signaling
Technology), cofilin (D3F9, 1:1000, Cell Signaling Tech-
nology), p-cofilin recognizing cofilin phosphorylated at
Ser3 (sc-271,921, 1:1000, Santa Cruz Biotechnology,
Inc.), ERK 2 recognizing ERK 1 and 2 (1:500, Santa Cruz
Biotechnology), p-ERK recognizing ERK 1 and 2 phos-
phorylated at Tyr204 (1:500, Santa Cruz Biotechnology),
CREB (1:1000, Cell Signaling Technology), p-CREB
recognizing CREB phosphorylated at Ser133 (1:1000,
Cell Signaling Technology), neuroligin-1 (sc-365,110,
1:500, Santa Cruz Biotechnology, Inc.), GAPDH
(1:15,000, Abcam), and β-actin (1:1000, Abcam). After
incubation with appropriate species-specific horseradish
peroxidase (HRP)-linked secondary antibodies (GE
Healthcare), the proteins were detected using enhanced
chemiluminescence substrates (GE Healthcare) and RT
ECL Imager (GE Healthcare) or G:BOX Chemi XRQ
(Syngene). Quantity One software (Bio-Rad) was used to
quantify the protein levels.
RNA extraction and real-time quantitative PCR analysis
RNA was extracted in TRI reagent following manufac-
turer’s protocol for RNA isolation. cDNA synthesis was
carried out using SuperScript III First-Strand Synthesis
System for RT PCR (Life Technologies). Target specific
PCR primers for mouse DHCR24 (5′-CAAGCCGTGGT
TCTTTAAGC-3′ and 5′-CATCCAGCCAAAGAGG-
TAGC), mouse TNFα (5′-CGAGTGACAAGCCTG-
TAGCC-3′ and 5′-GTGGGTGAGGAGCACGTAGT-
3′), mouse BDNF (5′-TGGCTGACACTTTTGAGCAC-
3′ and 5′-GTTTGCGGCATCCAGGTAAT-3′), mouse
NQO1 (5′-TAGCCTGTAGCCAGCCCTAA-3′ and 5′-
GCCTCCTTCATGGCGTAGTT-3′), mouse HMOX1
(5′-GTCAGGTGTCCAGAGAAGGC-3′ and 5′-GCG
TGCAAGGGATGATTTCC-3′), and mouse GAPDH
(5′-AACTTTGGCATTGTGGAAGG-3′ and 5′-ACA-
CATTGGGGGTAGGAACA-3′) were obtained from
TAG Copenhagen. FastStart SYBR Green Master
(Roche) was used for qPCR. The comparative ΔΔCt
method was used to calculate GAPDH-normalized
expression levels of the target mRNAs.
Lipid extraction and total cholesterol assay
To extract lipids for the total cholesterol measurement,
cells were homogenized in chloroform:isopropanol:Igepal
(7:11:0.1) mix and centrifuged for 10 min at 15000×g.
Supernatant was taken to a clean tube and air-dried at 50 °
C and put in a vacuum desiccator for 5 min. Fluorometric
Total Cholesterol Assay Kit (Cell Biolabs) was used to
measure the total cholesterol levels. The dried lipids ob-
tained from lipid extraction were dissolved in 200 μl assay
diluent, and 50 μl dissolved lipid sample was subjected for
the analysis. Cholesterol assay was performed according to
the manufacturer’s instructions, and the fluorescence signal
was measured with excitation wavelength at 560 nm and
emission wavelength at 590 nm using Fluorstar Galaxy
plate reader. Total cholesterol levels were normalized to
total protein levels of each sample.
Neuronal viability assay
Neuronal viability in the mouse primary cortical neuron
and BV2 microglial co-cultures was assessed as
described earlier [19]. Briefly, the cells were fixed in 4%
paraformaldehyde in PBS for 20 min and then incubated
in 0.3% H2O2 in methanol to permeabilize the cells and
block endogenous peroxidase activity. Incubation in
blocking solution containing 1% bovine serum albumin
and 10% horse serum for 20 min was used to prevent
non-specific staining. Neurons were stained by incuba-
tion with mouse anti-MAP2 primary antibody (1:2000,
Sigma) overnight at + 4 °C. Next, the cells were
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incubated with biotinylated horse anti-mouse secondary
antibody (1:500, Vector labs) for 1 h and ExtrAvidin-
HRP (1:500, Sigma) for another 1 h. The cells were
washed three times for 10 min in PBS between the anti-
body incubations. All antibody dilutions were prepared
in the blocking solution. Finally, ABTS Peroxidase
Substrate solution (Vector Labs) was prepared following
the manufacturer’s instructions and added onto the cells.
The absorbance was measured using a microtiter plate
reader (ELx808, BioTek or Infinite M200, Tecan) at
405 nm and was directly proportional to the number of
neurons in the wells. Six replicate wells per assay were
measured for each treatment. The measured background
absorbance from co-cultures incubated without the anti-
MAP2 primary antibody (negative controls, n = 6 per
assay) were averaged and subtracted from the
absorbances in the other wells. The absorbance in the
negative control wells was similar to the absorbance
measured from wells without any cells. Due to the
neuronal loss induced by neuroinflammation, the mean
neuronal viability obtained for each group in each
experiment was used to normalize BACE1 and Aβ40 levels.
Aβ, TNFα, NO, and ROS measurements
Conditioned media from the cell samples were collected
immediately before protein extraction and centrifuged at
10000×g for 10 min. Aβ40 levels in the conditioned
media were determined with monoclonal and HRP-
conjugated antibody-based Human/Rat β amyloid 40
ELISA kit (Wako, Osaka, Japan). Aβ40 concentrations
were normalized to neuronal viability. Mouse TNF alpha
ELISA Ready-SET-Go! kit (Affymetrix, San Diego, CA,
USA) was used for the detection of tumor necrosis fac-
tor α (TNFα) in the conditioned media. Nitric oxide
(NO) levels were determined using Griess Reagent Kit
for Nitrite Determination (G-7921, Life Technologies)
and normalized to neuronal viability determined by the
MAP2-ABTS assay described above. All kits were used
as instructed by the manufacturers. Reactive oxygen spe-
cies (ROS) levels in the co-cultures were measured using
fluorogenic probe 2′, 7′-Dichlorodihydrofluorescin
diacetate (DCFH-DA, Sigma D6883). One hour after
adding BV2 cells, samples were labeled with 120 μM
DCFH-DA for 30 min. Two hours after adding the BV2
cells, 5 h-neuroinflammation treatment was started. Sub-
sequently, cells were lysed using T-PER lysis buffer
(Thermo Scientific), and fluorescence was measured
using plate reader at 480 nm/530 nm.
Mouse primary hippocampal neuron culture, transient
transfection, and spine morphology analysis
Primary hippocampal neuronal cultures were prepared
from 18-day-old mouse JAXC57BL/6J embryos accord-
ing to the protocol previously described [20]. Briefly,
single-cell solution (240,000 cells/cm2) was plated on 8-
well chamber slides (LabTek) coated with poly-D-lysine
and 30 μg/ml laminin in feeding media composed of
Neurobasal medium supplemented with 2% B27,
0.5 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml
streptomycin. Hippocampal neurons were grown in a
cell culture incubator at 37 °C in 5% CO2. Half of the
culture media was replaced with fresh feeding media
after every 5 days in vitro. On DIV19, mature hippocam-
pal neurons in 8-well chamber slides were transiently
co-transfected with a mixture containing 2 μl of Lipofec-
tamine 2000 (Invitrogen) and 0.3 μg of control plasmid
DNA (pLenti-III-HA) or pLenti-CMV-h-DHCR24 and
0.3 μg enhanced green fluorescent protein (pEGFP).
Hippocampal neurons were fixed in 4% paraformalde-
hyde 24 h after transfection. Anti-DHCR24 antibody
(C59D8, 1:100, Cell Signaling Technology) was used for
immunofluorescence staining of DHCR24 in the hippo-
campal neurons. Hippocampal dendritic spines from
GFP-positive neurons were imaged with a Zeiss Axio
Observer.Z1 inverted microscope (63× NA 1.4 oil
objective) equipped with Zeiss LSM 800 confocal mod-
ule (Carl Zeiss Microimaging GmbH, Jena, Germany).
Serial Z-stacks of optical sections from dendritic seg-
ments were captured for spine analysis performed with
NeuronStudio software [21] as described previously [22].
Animals
Animal experimentation was carried out in accordance
with the national regulation and the Council of Europe
(Directive 86/609) of the usage and welfare of laboratory
animals. Experiments were approved by the Animal
Experiment Board of Finland. The JAXC57BL/6J male
mice were kept at the National Laboratory Animal
Centre at the University of Eastern Finland in a room
equipped with 12-h light/dark cycle and controlled
humidity. The mice were provided standard laboratory
animal chow and water ad libitum. All experiments were
carried out during the day light.
Injection of viral vectors and stroke surgeries
Total of 27 mice with the age of 3 months were random-
ized into following treatment groups: (1) lenti-GFP
injected sham mice (n = 7), (2) lenti-GFP injected
ischemic mice (n = 11), and (3) lenti-DHCR24 injected
ischemic mice (n = 9). The mice received lenti-GFP or
lenti-DHCR24 injections as described earlier with minor
modifications [23]. Shortly, the anesthesia was induced
using 5% isoflurane, and the mice were attached to the
stereotactic frame (David Kopf Instruments, Tujunga,
CA, USA). Surgical anesthesia was maintained using
1.8% isoflurane. Core body temperature was maintained
at 36.5 ± 0.5 °C using a homeothermic unit (PanLab,
Harvard Apparatus, Barcelona, Spain) connected to a
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rectal probe. An incision was made on the skin above
the injection site, and the skull was exposed. Two micro-
liters of the lenti-DHCR24 or lenti-GFP with the titer of
9.19 × 109 TU/ml and 1.87 × 109 TU/ml, respectively,
was injected unilaterally into the following coordinates:
+ 1.8 mm medial/lateral, 0.4 mm anterior/posterior, and
− 2.9 mm dorsal/ventral from the bregma. Viruses were
injected with a speed of 0.5 μl/min over a period of
4 min using a Hamilton syringe (Hamilton, NV, USA).
After the withdrawal of the needle, the skin was sutured
and the mice were allowed to wake up. Buprenorphine
0.03 mg/kg, i.p. (Temgesic 0.3 mg/ml), was used as
analgesic and was given immediately after the procedure.
Four weeks after the injection of the viral vectors, the
mice were subjected to transient occlusion of the middle
cerebral artery (tMCAO) or sham surgery as described
previously [24]. Briefly, the mice were anesthetized with
isoflurane as described above. Silicon-coated monofila-
ment with a diameter of 0.21 ± 0.02 mm (Doccol, MA,
USA) was inserted through external carotid artery,
advanced through the internal carotid artery to occlude
middle cerebral artery. After 45 min of occlusion, the
filament was withdrawn and the mice received 1 ml of
saline subcutaneously. Mice were then allowed to
recover in a heating chamber for 60 min and returned to
home cage kept on the heating pad for 24 h. Only half
of the cage was placed on heating pad to allow mice to
choose their environment. Sham mice underwent similar
procedure except that the filament was inserted and
withdrawn immediately. Total of six mice died after the
surgery from the following treatment groups: lenti-GFP
injected ischemic mice (n = 3) and lenti-DHCR24
injected ischemic mice (n = 3). In addition, one mouse
was excluded due to unsuccessful occlusion.
Magnetic resonance imaging and quantification of lesion
volumes
Magnetic resonance imaging (MRI) was performed in
anesthetized mice at 1 day post-injury for determination
of the lesion volume. MRI was carried out using a hori-
zontal 9.4 T (Agilent technologies, CA, USA) interfaced
with Agilent Direct Drive console as previously described
[25]. Multi-slice T2-weighted images were acquired with
echo time/repetition time of 40 ms/3000 ms, matrix size
128 × 256, field of view 19.2 × 19.2 mm2, slice thickness
0.8 mm, and number of slices 12. Images were analyzed
blinded to the study groups using Aedes software (Kuopio,
Finland) running under MatLab program (Math-works,
Natick, USA). The lesion volume was calculated using the
formula previously described in [26]. Specifically, the in-
farct volumes were obtained by multiplying the pixel size
by the slice thickness. The infarct volumes were quantified
using the following formula: Infarct volume = [volume of
left hemisphere − (volume of right hemisphere −
measured infarct volume)]/volume of left hemisphere
[26]. In addition, edema was calculated using the following
formula: Edema = (volume of right hemisphere − volume
of left hemisphere)/volume of left hemisphere. Both
infarct volume and edema were expressed as percentages.
The quantification was done by a researcher blinded to
the study groups.
Statistical analysis
Statistical significance between groups was tested using
independent samples t test or Mann-Whitney U test
(two groups) and one-way ANOVA followed by LSD
post-test or Kruskal-Wallis test followed by pairwise
comparisons with Mann-Whitney U test (three or more
groups) depending on whether the data fulfilled the
assumptions for parametric tests. Statistical significance
level was set at p < 0.05. All statistical analyses were
carried out using IBM SPSS Statistics 21.0.
Results
DHCR24 overexpression increases neuronal viability in
mouse primary cortical neuron-BV2 microglial co-cultures
upon neuroinflammation
Neuroprotective effects of DHCR24 have been exten-
sively studied in the context of several stress conditions,
including oxidative stress, ER stress, and apoptosis [3,
9–13, 18]. However, the role of DHCR24 in neuroin-
flammation, which is a key feature in several neurode-
generative diseases, has not been assessed previously.
For this purpose, we utilized co-cultures prepared from
embryonic mouse primary cortical neurons and mouse
BV2 microglial cells, which were treated with LPS and
IFN-γ to induce neuroinflammation at 5 days in vitro
according to [19]. Exponentially dividing BV2 microglial
cells were added to the E18 cortical cultures after 5 DIV
at the ratio of 1:5. Immunofluorescence analysis of co-
cultures at 7 DIV showed the expected number of BV2-
microglial cells as detected by CD11b staining (Fig. 1a).
Interestingly, the number of astrocytes, as detected by
GFAP staining, at 7 DIV was significantly increased by
approximately 2.5-fold (p < 0.001) after the addition of
BV2-microglial cells to the cortical cultures (Fig. 1a).
Next, we assessed the effect of LPS and IFN-γ specific-
ally on neuronal viability using MAP2-ABTS assay
according to [19] and observed an approximately 40%
reduction in the neuronal viability after LPS and IFN-γ
treatment as compared to vehicle-treated co-cultures at
DIV7. The reduction in neuronal viability was
accompanied with significantly increased levels of the
proinflammatory cytokine TNFα and NO (Fig. 1b). To
validate the neuroinflammation model, we pre-treated
co-cultures with an anti-inflammatory cytokine
interleukin-10 (IL-10) and with a selective inhibitor of
inducible nitric oxide synthase (iNOS; 1400 W) to test
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whether these pre-treatments affect the inflammation re-
sponse and neuronal viability. Pre-treatment with IL-10
decreased the TNFα levels in LPS- and IFN-γ-treated
cells by 60%, whereas it did not affect the neuronal
viability. Pre-treatment with the iNOS inhibitor 1400 W,
on the other hand, resulted in an average 90% reduction
in the NO, but not in the TNFα levels. The 1400 W
treatment also restored the neuronal viability to similar
level as in the vehicle-treated samples (Fig. 1b). LPS and
IFN-γ treatment of mouse primary cortical neuronal
cultures without addition of BV2 cells did not affect pro-
duction of TNFα or NO, or neuronal viability as
compared to vehicle-treated samples (data not shown).
Collectively, these results are consistent with previous
findings in the neuron-BV2 co-culture model upon neu-
roinflammation [19].
Next, we used lentivirus-mediated gene transduction
to overexpress human DHCR24 in the neurons at DIV4
prior to the addition of BV2 microglial cells at DIV5.
Subsequently, the neuron-specific expression of exogen-
ous DHCR24 resulted on average in threefold increase
in DHCR24 protein levels at DIV7 (Fig. 2a). Endogenous
or exogenous DHCR24 expression was not altered by
the induction of neuroinflammation (Fig. 2a). Western
Fig. 1 Characterization of the mouse primary cortical neuron and BV2 microglia co-cultures and effects of neuroinflammation. a Immunofluorescence
staining showed healthy MAP2-positive cortical DIV7 neurons in BV2 microglia co-cultures. Upper panel shows MAP2-positive (green) neurons and
GFAP-positive (red) astrocytes. Lower panel shows CD11b-positive (red) BV2 microglia cells (white arrow) in MAP2-positive cortical neuron (green) and
BV2 cell co-culture. Nuclei are stained with DAPI. Magnification × 20, scale bar 50 μm. The quantification of the data shows that the ratio of astrocytes
to neurons (white column) is significantly increased in the co-cultures compared to neurons only cultures. This might reflect either a true increase in
the amount of astrocytes or decreased amount of neurons due to addition of microglial cells. Black column indicates the ratio of BV2 microglial cells
to neurons at DIV7. b LPS and IFN-γ treatment was used to induce neuroinflammation in mouse primary cortical neuron and BV2 microglia co-cultures.
Neuronal viability decreased by 60% after induction of neuroinflammation. Pretreatment with iNOS inhibitor 1400 W (20 μM) prevented neuronal loss and
production of NO. Anti-inflammatory cytokine IL10 decreased TNFα levels, but had no effect on viability or NO levels. *p < 0.05, **p < 0.01, ***p < 0.001,
mean ± SEM, n = 23 (a), and n = 5–6 (b)
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blot-based analysis of BV2 microglial cells alone with
DHCR24-specific antibody revealed only low levels of
DHCR24, suggesting that the main portion of endogen-
ous DHCR24 in the co-cultures derives from the
neurons (data not shown). Treatment of the co-cultures
with LPS and IFN-γ decreased the neuronal viability as
expected based on the initial characterization of the
co-culture model. Importantly, the overexpression of
DHCR24 significantly increased the viability of
neurons in LPS- and IFN-γ-treated co-cultures as
compared to co-cultures transduced with the control
lentivirus (Fig. 2b). However, overexpression of
DHCR24 did not affect the production of TNFα or
NO, nor the activation of caspase-3 in the co-cultures,
which were all upregulated upon LPS- and IFN-γ-
induced neuroinflammation (Fig. 2c–e). We also
attempted to measure ROS levels 6 h after the induction
of neuroinflammation, but the ROS levels were below
detection level (data not shown). Collectively, these results
suggest that DHCR24 exerts neuroprotection in neuron-
BV2 cell co-cultures upon LPS- and IFN-γ-induced
neuroinflammation. However, it appears that the under-
lying neuroprotective mechanism(s) are not directly linked
to reduced inflammatory or apoptotic responses, or
decreased iNOS activity.
DHCR24 overexpression does not affect the levels of total
cholesterol but increases significantly the levels of
neuroligin-1 in mouse primary cortical neuron-BV2
microglial co-cultures upon basal conditions
Given the observed neuroprotection by DHCR24 overex-
pression upon LPS- and IFN-γ-induced neuroinflammation
in neuron-BV2 cell co-cultures, we next elucidated the ac-
tivity of well-established regulatory proteins involved in the
Fig. 2 DHCR24 overexpression increases neuronal viability without affecting TNFα, caspase-3, or NO levels in the neuron-BV2 cell co-cultures. a
DHCR24 levels were significantly increased after lentivirus-mediated gene transfer. Molecular masses in kilodaltons are indicated on the left side
of the blots. b Viability of mouse primary cortical neurons during LPS and IFN-γ treatment is significantly increased by DHCR24 overexpression.
The viability of vehicle-treated neurons overexpressing DHCR24 does not differ from the control cells. c TNFα levels were significantly increased
after LPS and IFN-γ treatment but unaffected by DHCR24 overexpression. d Pro-caspase-3-normalized activated caspase-3 levels were significantly
upregulated after LPS and IFN-γ treatment, whereas DHCR24 overexpression had no effect on caspase-3 activation. Western blot of caspase-3 is
shown in panel a. e NO levels did not significantly differ between DHCR24 overexpressing and control cells. NO levels in the vehicle-treated cells
were undetectable. *p < 0.05, **p < 0.01, ***p < 0.001, mean ± SEM, n = 6 (a, b, d), and n = 15–17 (c, e)
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survival and growth of neurons, namely Akt, ERK1, and
ERK2 [27, 28]. To do this, the phosphorylation status of
Ser473 in Akt (pAkt) and Tyr204 in ERK1/2 (pERK1/
pERK2) needed for the full activation of these kinases was
assessed (Fig. 3a). Although the induction of neuroinflam-
mation significantly augmented the phosphorylation of Akt
(pAkt/Total Akt), the overexpression of DHCR24 did not
modulate the Akt activation. Conversely, the levels of
pERK2 were decreased, while pERK1 levels remained
unchanged after normalization to the total levels of ERK1/
ERK2 upon neuroinflammation (Fig. 3a). The activation of
ERK1 or ERK2 was not affected by the overexpression of
DHCR24. To further delineate the molecular mechanism




















Fig. 3 DHCR24 overexpression does not affect the levels of total cholesterol, but increases significantly the levels of NLG1 in the neuron-BV2 cell
co-cultures. a Western blotting was used to detect the levels of total and phosphorylated forms of Akt, ERK1, and ERK2. DHCR24 overexpression
had no significant effect on the levels of these proteins. However, the total Akt levels decreased, and phosphorylated Akt levels increased upon
LPS and IFN-γ treatment. Phosphorylated ERK2 levels were significantly reduced after LPS and IFN-γ treatment. b Levels of total CREB are
decreased in both control and DHCR24-overexpressing co-cultures upon LPS and IFN-γ treatment. Phosphorylation of CREB is increased upon LPS
and IFN-γ treatment. Western blot samples in the figure are from the same membrane. c The overexpression of DHCR24 significantly increased
NLG1 levels upon basal growth conditions in primary neuron-BV2 cell co-cultures. A similar trend towards increase was also observed in
co-cultures overexpressing DHCR24 upon LPS and IFN-γ treatment. The assessment of phosphorylation status of cofilin-1 at Ser 3 did not show statically
significant changes between DHCR24-overexpressing or control co-cultures after vehicle or LPS and IFN-γ treatments. The induction of neuroinflammation
per se significantly reduced the phosphorylation cofilin-1 at Ser 3. d Total protein-normalized total cholesterol levels in control and DHCR24-overexpressing
co-cultures upon vehicle and LPS and IFN-γ treatments do not show statistically significant changes between groups. Vehicle control was normalized to
100%. *p < 0.05, **p < 0.01, ***p < 0.001, mean ± SEM, n = 6 (a, b), n = 3 (c), and n = 7 (d)
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neuron-BV2 cell co-cultures, the Ser133 phosphorylation
of cAMP response element-binding protein (CREB) was
evaluated. The binding of activated form of this transcrip-
tion factor to the cAMP response elements modulates the
transcription of the downstream genes involved in neur-
onal survival [29]. As with Akt, the activation of CREB
was observed upon the induction of neuroinflammation in
neuron-BV2 cell co-cultures without any statistically
significant modulation by the overexpression of DHCR24
(Fig. 3b). Elucidation of neuroligin-1 (NLG1) levels
revealed a statistically significant increase in DHCR24
overexpressing neuron-BV2 cell co-cultures upon basal
growth conditions. A similar trend (p = 0.066) was
observed in DHCR24 overexpressing neuron-BV2 cell co-
cultures upon neuroinflammation (Fig. 3c). Importantly,
since NLG1 regulates the dendritic spines and synaptic
plasticity via LIMK1/cofilin-mediated actin reorganization,
we next determined the phosphorylation status of cofilin
at Ser 3 (p-cofilin), which is a reliable indicator of cofilin
activity [30]. Although the assessment of total cofilin-
normalized p-cofilin levels revealed a strong reduction
upon neuroinflammation as compared to basal growth
conditions, the levels of p-cofilin were unaltered in
neuron-BV2 co-cultures overexpressing DHCR24 in both
basal conditions and under neuroinflammation as com-
pared to control co-cultures (Fig. 3c). Finally, given the en-
zymatic role of DHCR24 in the production of cholesterol
from desmosterol and the evidence that the disruption of
cholesterol metabolism modulates synaptic function and
survival [31], the total cellular cholesterol levels were
measured from the vehicle and LPS/IFN-γ-treated
neuron-BV2 cell co-cultures transduced with DHCR24 or
control lentiviruses (Fig. 3d). The total cellular cholesterol
levels normalized to total protein levels (including both
cholesterol esters and free cholesterol) were not statistically
increased in the DHCR24-overexpressing co-cultures as
compared to control co-cultures upon neuroinflammation
(Fig. 3d). These findings altogether suggest that DHCR24
does not exert neuroprotection in the neuron-BV2 cell co-
cultures upon neuroinflammation via modulation of the
well-established neuronal survival pathways regulated by
Akt, ERK1/2, or CREB. Also, the improved neuronal
survival upon neuroinflammation does not associate with
significantly increased total cholesterol levels, but could be
linked to improved synaptic plasticity via increased protein
levels of NLG1 upon overexpression of DHCR24.
DHCR24 overexpression reduces the maturation of APP in
mouse primary neuron-BV2 microglia co-cultures upon
neuroinflammation
Keeping in mind the intimate link between cholesterol
and APP [32], we next assessed the effects of DHCR24
on APP processing and the generation of Aβ in the
neuron-BV2 co-cultures upon LPS- and IFN-γ-induced
neuroinflammation (Fig. 4). The induction of neuroin-
flammation significantly affected the maturation of
neuron-specific APP695 isoform by increasing the ratio
of APP mature vs. APP immature (APPm/im) in the con-
trol- but not in the DHCR24-transduced co-cultures
(Fig. 4a). Conversely, the total levels or maturation of
APP695 isoform remained unaffected by the overexpres-
sion of DHCR24 in the co-cultures upon normal growth
conditions. A potential caspase-cleaved fragment of APP
(> 60 kDa) [33] was detected in the LPS- and IFN-γ-
treated samples, but there were no changes in the levels
of this fragment between DHCR24- and control-
transduced samples (Fig. 4a, data not shown). Finally,
the overexpression of DHCR24 did not affect the levels
of BACE1 in the total protein lysates or the levels of
Aβ40 in the conditioned media (Fig. 4b, c). Given the
fact that BACE1 and APP695 isoform are abundantly
expressed in the neurons, BACE1 levels were normalized
to the neuronal viability in the co-cultures. Although the
levels of BACE1 were significantly augmented due to the
induction of neuroinflammation, the levels of BACE1
were not significantly altered in co-cultures overexpress-
ing DHCR24 as compared to control samples upon neuro-
inflammation (Fig. 4b). Similarly, the normalization of
Aβ40 levels to neuronal viability did not reveal significant
changes between DHCR24- and control-transduced
samples (Fig. 4c). These findings suggest that the neuron-
specific maturation of APP695 is reduced due to the
overexpression of DHCR24 in the mouse primary neuron
and BV2 microglia co-cultures upon neuroinflammation,
coinciding with the increased neuronal viability.
The overexpression of DHCR24 increases total dendritic
spine and mushroom spine density in mouse
hippocampal neurons
We next assessed the potential effects of DHCR24 on
synapses by determining the dendritic spine number and
morphology in mature mouse hippocampal neurons
(DIV20) upon normal growth conditions. It has been
previously shown that the local cholesterol synthesis as
well as membrane cholesterol levels are key factors in
regulating the development of mature synapses and
spine density [34]. Immunofluorescence confocal micro-
scope analysis showed endogenous DHCR24 expression
in the soma of GFP plasmid-transfected mouse
hippocampal neurons (Fig. 5a, top row). Hippocampal
neurons co-transfected with DHCR24 and GFP plasmids
(Fig. 5a, bottom row) showed also prominent staining of
DHCR24 in the dendrites of the GFP-positive neurons.
No immunofluorescence signal was detected in control
neurons, which were mock-transfected and incubated
only with secondary antibody (data not shown). Conse-
quently, the effects of DHCR24 on the dendritic spine
morphology (classified as mushroom, thin, and stubby
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subtypes), head size, and the total spine number were
determined (Fig. 5b). Quantitative analysis revealed that
the overexpression of DHCR24 significantly increased
the total and mushroom spine density as compared to
control plasmid-transfected neurons. The head sizes of
the mushroom, thin or stubby spines were not affected
by the overexpression of DHCR24 (data not shown).
These data suggest that the overexpression of DHCR24
promotes increase in dendritic spine density in mature
hippocampal neurons.
Lentivirus-mediated striatal overexpression of DHCR24
decreases ischemia-induced lesion size
In order to elucidate the neuroprotective efficacy of
DHCR24 in vivo, C57BL/6J mice were intrastriatally
injected with lentiviral vector encoding DHCR24 or GFP
(control). Intrastriatal injection of the lentivirus yielded a
relatively local overexpression as detected by GFP fluor-
escence induced by the injection of control lentivector
encoding GFP, spanning within approximately 1.6-mm
area at the injection site (Fig. 6b). The injected mice
were subjected to tMCAO 3 weeks after the injection of
lentiviral vectors. Quantification of the MRI images
taken at 1 day after stroke revealed very local, yet signifi-
cant protection against ischemia-induced cell death
locally at the DHCR24 lentivirus injection site (Fig. 6a).
Figure 6b illustrates typical lesion images of GFP and
DHCR24 lentiviral vector injected mice taken at the stri-
atal level close to the lentivirus injection site. The
decrease in the lesion size reached statistical significance
at the striatal level on the 3rd imaged slice (Fig. 6c),
without any effect on the extent of edema (Fig. 6d).
Western blot analysis of the protein homogenates from
the whole striatum using an antibody against DHCR24
confirmed the increased expression of DHCR24 in the
DHCR24 lentivirus-injected ischemic mouse striatum
(Fig. 6e). Furthermore, qPCR showed a statistically
significant increase in the GAPDH-normalized mRNA
levels of DHCR24 in DHCR24 lentivirus-injected
ischemic striatal samples as compared to GFP-control
lentivirus-injected ischemic striatal RNA-samples
(Fig. 6e). In order to elucidate the potential molecular
mechanism underlying the reduced lesion size in stri-
atum upon DHCR24 overexpression, the protein levels
Fig. 4 APP, BACE1, and Aβ40 levels are not affected by DHCR24 overexpression or neuroinflammation in the neuron-BV2 cell co-cultures. a West-
ern blotting was used to detect the levels of mature (APP695m), immature (APP695im), and total APP (APPtot, calculated as APP695m + APP695im).
There were no significant differences in the levels of APPm, APPim, and APPtot. However, the ratio between mature and immature APP695 forms
was significantly increased in the LPS and IFN-γ-treated control co-cultures. An APP fragment of approximately 60 kDa (APP*) was detected in the
LPS and IFN-γ-treated samples, probably resulting from caspase-mediated cleavage of APP. DHCR24 overexpression did not affect the levels of this
fragment. Molecular masses in kilodaltons are indicated on the left side of the blots. APP751 isoform derived from glial cells is indicated as with
the asterisk (*) above the APP695m and APP695im bands. b The levels of BACE1 normalized to neuronal viability are increased upon LPS and IFN-γ
treatment, but DHCR24 overexpression has no effect on BACE1 levels. c Aβ40 was detected from conditioned media using ELISA. Decreased levels
of Aβ40 were detected in the LPS and IFN-γ-treated samples. This was possibly due to neuronal loss in these samples as normalization of Aβ40
levels to neuronal viability abolished the effect. Aβ40 levels were not significantly affected by DHCR24 overexpression. *p < 0.05, **p < 0.01,
mean ± SEM, n = 6
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of NLG1 were determined from the striatal whole cell
lysates (Fig. 6f ). The total levels of NLG1 were not al-
tered between DHCR24 overexpressing and control sam-
ples in striatum. Interestingly, however, maturation of
NLG1 (the ratio of mature (m) and immature (im) forms
of NLG1; NLG1-m/im) showed a moderate increase in
DHCR24 overexpressing mice, but this did not reach
statistical significance (Fig. 6f ). Finally, we investigated
whether the mRNA levels of tumor necrosis factor-α
(TNFα), brain-derived growth factor (BDNF), heme
oxygenase-1 (HMOX1), and NAD(P)H quinone
oxidoreductase-1 (NQO1) are changed in ischemic stri-
atal samples due to the overexpression of DHCR24 using
qPCR. TNFα is a marker for inflammation [19], and
BDNF is associated with neuronal survival, differenti-
ation and neuronal plasticity [35], while HMOX1 and
NQO1 are up-regulated in response to oxidative stress
[36, 37]. Consequently, GAPDH-normalized mRNA
levels of TNFα, BDNF, HMOX1, or NQO1 did not show
statistically significant changes in the ischemic brain
tissue upon overexpression of DHCR24 (Additional file 1:
Figure S1). Collectively, these data suggest that the over-
expression of DHCR24 is able to significantly, yet locally,
mitigate the ischemia-induced damage in a mouse model
of transient focal cerebral ischemia without significantly
affecting the inflammatory, neurotrophic or oxidative
stress responses.
Discussion
DHCR24 has previously been shown to protect neuronal
cells in different stress conditions, including oxidative
stress, ER stress, Aβ toxicity, and apoptosis [3, 9–13].
Here, we report for the first time that the overexpression
of DHCR24 enhances neuronal viability in neuron-BV2
microglial cell co-cultures upon LPS- and IFN-γ-
induced neuroinflammation, increases the total number
of dendritic spines and the proportion of mushroom
spines in mature mouse hippocampal neurons, and is
neuroprotective in a mouse experimental model of
cerebral stroke. Moreover, our data suggest that the neu-
roprotection elicited by the overexpression of DHCR24
upon neuroinflammation is not related to significantly
altered proinflammatory cytokine response, total cellular
cholesterol levels or the activity of proteins linked with
neuroprotective signaling, such as Akt, ERK, or CREB.
Conversely, the protein levels of NLG1, which is a well-
established post-synaptic adhesion protein involved in
synaptic plasticity [30, 38, 39], were increased in
neuron-BV2 co-cultures upon the overexpression of
DHCR24 particularly in the basal growth conditions.
Fig. 5 Overexpression of DHCR24 increases total and mushroom spine density in mouse hippocampal neurons. a Immunofluorescence staining of mouse
hippocampal neurons (DIV20) with DHCR24 antibody. Neurons were transiently transfected with control + GFP plasmids (top row), or DHCR24 + GFP
plasmids (lower row), where the white arrow points to the GFP and DHCR24-positive dendrite. Magnification of the GFP-positive cell soma and part of the
dendrite inside the white box is shown next to the overlay picture. Magnification × 63, scale bars 20 μm. b Representative images of dendritic segments
transiently transfected either with control or DHCR24 plasmid. Spine density quantification demonstrates that transient overexpression of DHCR24
significantly increases total spine density and mushroom spine density per micrometer in hippocampal neurons (DIV20). *p < 0.05, mean ± SEM, n = 40
(the total number of neurons analyzed from three independent experiments). Magnification 63×, zoom 3×. Scale bar 1 μm
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Fig. 6 DHCR24 overexpression decreases lesion size after middle cerebral artery occlusion in mice. a Lentivirus-mediated overexpression of GFP control or
DHCR24 in mouse brain was induced 3 weeks prior to the tMCAO. Lesion size quantification at 1 day after tMCAO from 12 consecutive image planes
revealed a significant reduction in the lesion size at the third imaged plane corresponding to the area where the lenti-GFP control (white circle) or
lenti-DHCR24 (black circle) injections were done. b Representative MRI images of the GFP control and DHCR24 groups. Dotted line surrounds the
ischemic lesion in the lenti-GFP control brain. Right panel demonstrates the local expression of GFP after striatal lentiviral vector injection,
representative images of 3 coronary brain sections 0.8 mm apart (× 4 magnification, scale bar 200 μM). c Quantification data of the third imaged plane
in reveals statistically significantly decreased infarction volume in DHCR24-injected animals compared to those injected with GFP control. d Lenti-DHCR24
injection had no effect on the extent of edema at the third imaged plane. eWestern blotting was used to detect the protein levels of DHCR24 and GFP in
the whole mouse striatum after lentiviral injection. Molecular masses in kiloDaltons are indicated on the left side of the blots. Less-than sign in the blot
picture denotes an unspecific band. Quantification of DHCR24 with qPCR was used to detect the mRNA and Western blot to detect protein levels in the
same samples. f The levels of mature (NLG1-m), immature (NLG1-im), and total levels (NLG1-m + NLG1-im) of NLG1 were determined from mouse striatum.
The whole protein lysates of DHCR24 overexpressing and control samples were analyzed using Western blotting. Total protein lysate from mouse
hippocampal primary neuronal cultures (HC) was used as control. In all graphs *p < 0.05, **p < 0.01, mean ± SEM, n = 6
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These data suggest that yet undefined neuroprotective
mechanism(s) may underlie the improved neuronal
survival induced by the overexpression of DHCR24 in
the used in vitro and in vivo models.
Prior studies have linked the neuroprotective effects of
DHCR24 directly to its cholesterol-synthesizing activity,
showing cholesterol-dependent protection from oxida-
tive stress [11] or Aβ toxicity [9] and maintenance of
lipid raft integrity [10]. Here, a moderate, but statistically
non-significant increase in total cellular cholesterol
levels was detected, and this coincided with enhanced
neuronal survival in the DHCR24-overexpressing
neuron-BV2 co-cultures after the induction of neuroin-
flammation. However, it is possible that the moderately
increased total cholesterol levels may simply reflect the
increased number of cholesterol-rich neurons rather
than increased DHCR24-mediated local synthesis of
cholesterol. Also, owing to the fact that only the total
cellular cholesterol levels were determined, it is impos-
sible to specifically define whether the overexpression of
DHCR24 specifically affected the levels of free choles-
terol or cholesterol esters upon neuroinflammation. We
also detected increased total and mushroom spine
density in the mature mouse hippocampal neurons
overexpressing DHCR24 upon basal growth conditions.
This is an important finding as dendritic spines are
dynamic structures tightly regulated by membrane lipid
composition [40, 41]. Thus, it could be hypothesized
that a local increase in cholesterol synthesis by transient
DHCR24 overexpression may facilitate spine formation
in dendrites. Recently, it was suggested that cholesterol
levels modulate the NMDA receptor (NMDAR) activity
[42], while the activation of NMDAR in turn triggered
downstream signaling, promoting either cell survival or
cell death [43]. In the present study, the overexpression
of DHCR24 did not significantly modulate PI3K/Akt,
ERK1/2-mediated MAP kinase, or CREB signaling
pathways associated with neuronal survival and growth,
suggesting that these pathways do not play a major role
in the DHCR24-mediated neuroprotection upon LPS- and
IFN-γ-induced neuroinflammation. Conversely, upon
basal growth conditions, the overexpression of DHCR24
significantly augmented the protein levels of NLG1 in
neuron-BV2 microglial cell co-cultures, and after the
induction of neuroinflammation, a similar trend was
observed upon the overexpression of DHCR24. This is an
important finding given that the augmented levels of
NLG1 have been shown to increase the spine and synapse
growth in cultured neurons [38, 39], emphasizing the
central role of NLG1 in retaining the synaptic plasticity
and integrity. Recently, it was further established that
NLG1 regulates the dendritic spines and synaptic plasti-
city via LIMK1/cofilin-mediated actin reorganization [30].
More specifically, it was shown that NLG1 activates
LIM-protein kinase (LIMK1), which in turn promotes
the activation of cofilin through the phosphorylation
of cofilin at Ser 3. Consequently, the Ser 3 phosphorylated
form of cofilin promotes actin assembly, which then facili-
tates spine and synapse formation as well as long-term
potentiation. In the present study, however, we did not
observe a significant increase in the cofilin phosphorylation
at Ser 3 upon overexpression of DHCR24 in neuron-BV2
microglial co-cultures, suggesting that molecular mecha-
nism(s) other than NLG1/LIMK1/cofilin-mediated actin
reorganization underlies the observed neuroprotection
upon the overexpression of DHCR24 in co-cultures under
neuroinflammation.
Increased plasma cholesterol content has been previ-
ously shown to inhibit the maturation of APP during
cellular aging [44], suggesting that the age-associated
alterations in relation to cholesterol content are
instrumental for cellular functions. Here, we observed
enhanced maturation of the APP695 isoform in the
control co-cultures upon the induction of neuroinflam-
mation, while a similar increase was not detected in the
DHCR24-overexpressing co-cultures. Importantly, APP
maturation changes were evident only in the stress-
induced, but not in the basal growth conditions, and
were not associated with significantly altered levels of
BACE1 or Aβ. Several lines of evidence suggest that
cholesterol is a central component regulating synaptic
function and plasticity [14, 40]. Cholesterol and sphingo-
lipids are enriched in the membranes of dendritic spines,
and alterations in the levels of these lipids modulate
spine morphology and synaptic activity via affecting the
arrangement of actin cytoskeleton and the trafficking of
NMDA receptors [40]. Moreover, it has been shown that
the reduced synthesis of total brain cholesterol is a
prominent feature in aging individuals and AD patients
[45–47]. This is in line with the recent findings showing
that constitutive loss of hippocampal cholesterol impairs
cognition in old rats through an Akt-mediated molecular
mechanism, leading to reduced hippocampal long-term
potentiation [41].
In addition to the cholesterol-synthesizing activity,
previous studies have demonstrated that DHCR24 has a
direct H2O2-scavenging activity, which is able to protect
cells from oxidative stress [3, 11, 12]. Also, DHCR24
overexpression-mediated protection from ER-stress-
induced apoptosis was recently linked to decreased ROS
levels [12]. Thus, it is possible that the protection from
neuroinflammation-induced neuronal death is also
linked to ROS-scavenging feature by DHCR24. Here, the
measurements of ROS levels 6 h after the induction of
neuroinflammation in neuron-BV2 cell co-cultures did
not reveal any quantifiable ROS production, suggesting
that ROS are not produced in the early phases of neuro-
inflammation in this model. Neuroprotective effects of
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DHCR24 have also previously been linked to the re-
duced activation of caspase-3 [3, 12], and increased
caspase-3 activation was observed when DHCR24 was
downregulated in the neuroblastoma cells [18]. Here, the
neuronal viability was increased in DHCR24-overexpressing
neuron-BV2 cell co-cultures, but DHCR24 did not alleviate
caspase-3 activation, indicating that the neuroprotective
effect of DHCR24 was not mediated via inhibition of
caspase-3 activity. This was also reflected by the unaltered
levels of caspase-cleaved ~ 60 kDa APP fragment between
DHCR24- and control-transduced neuron-BV2 cell
co-cultures upon neuroinflammation.
We also observed that the lentivirus-mediated overex-
pression of DHCR24 in striatum reduced the ischemia-
induced lesion size in a mouse model of transient focal
ischemia. MRI images taken at 1 day after stroke
revealed a very local, yet significant protection against
ischemia-induced cell death (infarct volume) at the close
proximity of the lentivirus injection site without any
significant effect on edema. Although the protection was
very local as the overexpression of the construct did not
spread through the injected hemisphere, it provides a
proof of principle that DHCR24 is able to confer protec-
tion also in vivo. Furthermore, it is expected that the
local DHRC24 levels are higher near the injection site
similar to that seen with GFP, which in turn could
explain why the analyses conducted from the whole cell
extracts showed a significant increase only in the mRNA
levels of DHCR24, but not in the protein levels. Owing
to the fact that the increased levels of NLG1 in the
neuron-BV2 cell co-cultures upon the overexpression of
DHCR24 were observed, a similar assessment of NLG1
was done in mouse striatal brain tissue. The total protein
levels of NLG1 were not significantly altered, while the
maturation of NLG1 (measured as the increased ratio of
NLG1-m vs. NLG1-im) showed a trend towards an
increase in the DHCR24-transduced striatal samples.
NLG1 is known to be N- and O-glycosylated [48], but
the exact role of this maturation process in the context
of synaptic plasticity is not well-established. Thus, it
remains to be determined whether enhanced maturation
of NLG1 is related to neuroprotective functions upon
different acute stress conditions. Finally, elucidation of
the expression profile of TNFα, BDNF, HMOX1, and
NQO1 did not reveal alterations in mice overexpressing
DHCR24 as compared to control mice, suggesting that
DHCR24 is able to locally mitigate the ischemia-induced
damage in a mouse model of transient focal cerebral
ischemia without significantly affecting the inflamma-
tory, neurotrophic, or oxidative stress responses. Collect-
ively, the findings in the present study are in line with a
previous study showing that DHCR24 exerts cholesterol-
dependent neuroprotection in an experimental stroke
model in mice, in which DHCR24 was genetically
downregulated [49]. More specifically, it was suggested
that the underlying molecular mechanism of DHCR24 is
linked to the maintenance of lipid raft integrity in
astrocytes by assuring the EAAT2-mediated uptake of
glutamate excess upon ischemic stress [49]. This is an
interesting mechanistic finding also in the context of the
present study, as we observed that the number of
astrocytes significantly increased after the addition of
BV2 microglial cells to the neuronal cultures before the
induction of neuroinflammation. Thus, increased
expression of DHCR24 also in the astrocytes, and not
exclusively in the neurons, might also contribute to the
improved neuronal survival upon neuroinflammation in
our co-culture model. Taken together, the two in vivo
studies conducted in different experimental stroke
models reinforce the key role of DHCR24 in molecular
processes underlying neuroprotection.
Conclusions
Collectively, our data indicate that the augmentation of
DHCR24 expression is neuroprotective both in vitro and
in vivo. Increased levels of DHCR24 protect the neurons
during neuroinflammation and brain ischemia and
promote synaptic and neuronal health by supporting
dendritic spine formation upon basal growth conditions.
Together with previous reports, our findings suggest that
DHCR24 may exert neuroprotective effects in different
stress conditions linked to AD and other neurodegenera-
tive diseases and thus may prove as a useful target when
considering new therapeutic strategies against synaptic
dysfunction and neurodegeneration.
Additional file
Additional file: Figure S1. Overexpression of DHCR24 does not
significantly alter the mRNA levels of TNFα, BDNF, HMOX1, and NQO1
in the whole mouse striatum after middle cerebral artery occlusion.
GAPDH-normalized TNFα, BDNF, HMOX1, and NQO1 mRNA levels in the
whole mouse striatum determined using qPCR do not indicate changes
in the striatum between DHCR24 overexpressing and control lentivirus-
transduced mice after tMCAO. Mean ± SEM, n = 6. (PDF 228 kb)
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